Cabenuva 600mg/900mg-3ml 600mg/3ml + 900mg/3ml KIT

Cabenuva 600mg/900mg-3ml

Active Ingredient:
Cabotegravir + Rilpivirine
Form:
KIT
Brand:
Cabenuva 600mg/900mg
Origin:
AUSTRALIA

Buy Cabenuva 600mg/900mg-3ml Cabotegravir + Rilpivirine

Cabenuva 600mg/900mg-3ml is a long-acting injectable kit combining cabotegravir and rilpivirine for HIV maintenance therapy. This two-drug regimen supports viral suppression with monthly dosing. Ideal for patients stable on antiretroviral treatment seeking simplified regimens.

Strength

600mg/3ml + 900mg/3ml

Pack Size

1s

Storage

2-8°

Manufacturer / TM Owner

ViiV Healthcare

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Uses / Indications

  • Cabenuva 600mg/900mg-3ml is used for HIV maintenance therapy in adults who are virologically suppressed. It combines two antiretrovirals, cabotegravir and rilpivirine, to maintain viral suppression with less frequent dosing. This kit is designed for patients who have achieved stable viral loads on prior regimens. It is not intended for initial HIV treatment or in cases of resistance to either component.

Side Effects

  • Cabenuva 600mg/900mg-3ml provides sustained drug levels to maintain viral suppression over time. The combination works systemically to inhibit viral replication. Patients may experience injection site reactions or systemic effects common to injectable therapies. Regular dosing supports consistent therapeutic levels.

Precautions & Warnings

  • Store Cabenuva 600mg/900mg-3ml refrigerated between 2–8°C and protect from light. Do not freeze. Administer only by healthcare professionals trained in injectable HIV therapies. Monitor for hypersensitivity or injection-related reactions. Ensure proper handling to maintain sterility and potency.

Avoid Interactions

  • Cabenuva 600mg/900mg-3ml may interact with drugs that affect CYP3A enzymes, including certain anticonvulsants and rifamycins. Avoid concurrent use with strong CYP3A inducers due to potential loss of virologic control. Consult a healthcare provider before combining with other medications. Alcohol and over-the-counter products may also interact.

References

Frequently Asked Questions

It is used for HIV maintenance therapy in adults who are virologically suppressed on prior antiretroviral regimens.

It is administered as a monthly injection by a healthcare professional.

No, it is not intended for initial HIV treatment or in patients with resistance to cabotegravir or rilpivirine.

Common effects may include injection site reactions and systemic responses typical of injectable therapies.

No, it requires administration by a healthcare professional and is prescribed for appropriate patients.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Cabotegravir + Rilpivirine

Cabenuva 600mg/3ml

Cabenuva 600mg/3ml

600mg/3ml + 900mg/3ml KIT
Cabenuva 600mg/3ml

Cabenuva 600mg/3ml

600mg/3ml + 900mg/3ml KIT
Cabenuva 600mg/900mg-3ml

Cabenuva 600mg/900mg-3ml

600mg/3ml + 900mg/3ml KIT

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT